These findings prompted the authors to conclude that remote systems used at home by patients with type 1 diabetes on intensive insulin therapy improve their glycemic control but need to support real-time data transmission and be combined with appropriate data analysis and subsequent decision-making for glycemic control to achieve any real improvement in the quality of care. This evidence concerns the gene INS and type 1 diabetes mellitus.